We investigated the contractile role of M 2 muscarinic receptors in mouse urinary bladder. When measured in the absence of other agents, contractions elicited to the muscarinic agonist oxotremorine-M exhibited properties consistent with that expected for an M 3 response in urinary bladder from wild-type and M 2 knockout (KO) mice. Evidence for a minor M 2 receptormediated contraction was revealed by a comparison of responses in M 3 knockout and M 2 /M 3 double knockout mice. Treatment of wild-type and M 2 knockout urinary bladder with N-2-chloroethyl-4-piperidinyl diphenylacetate (4-DAMP mustard) caused a large inhibition of the muscarinic contractile response. The residual contractions were much smaller in M 2 knockout bladder compared with wild type, suggesting that M 2 receptors rescue the muscarinic contractile response in wildtype bladder following inactivation of M 3 receptors with 4-DAMP mustard. When measured in the presence of prostaglandin F 2␣ and isoproterenol or forskolin, oxotremorine-M mediated a potent contractile response in urinary bladder from M 3 KO mice. This response exhibited an M 2 profile in competitive antagonism studies and was completely absent in M 2 /M 3 KO mice. Following 4-DAMP mustard treatment, oxotremorine-M elicited a contractile response in wild-type urinary bladder in the presence of KCl and isoproterenol or forskolin, and this response was diminished in M 2 KO mice. Our results show that the M 2 receptor mediates contractions indirectly in the urinary bladder by enhancing M 3 receptor-mediated contractions and inhibiting relaxation. We also show that it is difficult to detect M 2 receptor function in competitive antagonism studies under conditions where a simultaneous activation of M 2 and M 3 receptors occurs.
4-DAMP mustard. When measured in the presence of prostaglandin F 2␣ and isoproterenol or forskolin, oxotremorine-M mediated a potent contractile response in urinary bladder from M 3 KO mice. This response exhibited an M 2 profile in competitive antagonism studies and was completely absent in M 2 /M 3 KO mice. Following 4-DAMP mustard treatment, oxotremorine-M elicited a contractile response in wild-type urinary bladder in the presence of KCl and isoproterenol or forskolin, and this response was diminished in M 2 KO mice. Our results show that the M 2 receptor mediates contractions indirectly in the urinary bladder by enhancing M 3 receptor-mediated contractions and inhibiting relaxation. We also show that it is difficult to detect M 2 receptor function in competitive antagonism studies under conditions where a simultaneous activation of M 2 and M 3 receptors occurs.
Micturition is mediated through the actions of several neurotransmitters. Among those that directly influence the tone of urinary bladder smooth muscle, acetylcholine is important in contracting the reservoir and relaxing the outlet through activation of muscarinic receptors (de Groat and Yoshimura, 2001 ). Most evidence shows that it is the M 3 subtype of the muscarinic receptor that mediates the direct contractile response to acetylcholine in the urinary bladder. For example, the contractile response to muscarinic agonists exhibits an M 3 profile in competitive antagonism studies (Noronha-Blob et al., 1989; Longhurst et al., 1995; Choppin and Eglen, 2001) , and these contractions are nearly absent in urinary bladder from M 3 muscarinic receptor knockout (M 3 KO) mice (Matsui et al., 2000) . Male M 3 KO mice exhibit prominent urinary bladder distension in vivo, demonstrating the essential role of the M 3 receptor in micturition (Matsui et al., 2000) . The small, direct contractile response that persists in urinary bladder from M 3 KO mice is completely lost in mice lacking both M 2 and M 3 muscarinic receptors (M 2 /M 3 KO mice), demonstrating that the M 2 receptor is capable of mediating very small contractions and that muscarinic recep-tors other than M 2 and M 3 do not seem to mediate direct contraction of the urinary bladder (Matsui et al., 2002) .
The signaling mechanisms of M 2 and M 3 muscarinic receptors in smooth muscle are consistent with their respective roles in contraction. The M 3 receptor interacts with G q/11 to mediate phosphoinositide hydrolysis (Noronha-Blob et al., 1989; Candell et al., 1990; Roffel et al., 1990; Zhang and Buxton, 1991) and Ca 2ϩ mobilization, which is essential for contraction, whereas the M 2 receptor interacts with G i/o to mediate responses that are ultimately contingent upon activation of other Ca 2ϩ -mobilizing receptors, such as the M 3 . For example, M 2 receptors mediate an inhibition of adenylyl cyclase (Noronha-Blob et al., 1989; Candell et al., 1990; Yang et al., 1991; Zhang and Buxton, 1991) . In smooth muscle, cAMP causes relaxation (Conti and Adelstein, 1980; Kerrick and Hoar, 1981; Ruegg et al., 1981) ; thus, activation of the M 2 receptor has the potential to mediate an inhibition of the relaxant effects of forskolin or ␤-adrenoceptors on contractions elicited through activation of a G q -linked receptor. We refer to this type of contractile mechanism as indirect, because it represents an inhibition of relaxation and not a direct mediation of contraction. The M 2 receptor has also been shown to mediate an inhibition of Ca 2ϩ -activated K ϩ channels (Cole et al., 1989; Kume et al., 1992; Wade and Sims, 1993) . Through this mechanism, the M 2 receptor would be expected to diminish the inhibitory effects of Ca 2ϩ -activated K ϩ channels on the contraction mediated by other Ca 2ϩ -mobilizing receptors. This potential muscarinic mechanism is also indirect, because M 2 receptor activation is expected to have little effect by itself but nonetheless enhances the effect of other contractile receptors. It has been demonstrated through mathematical modeling that a response mediated through an interaction between directly and indirectly acting receptors has a tendency to display the pharmacological profile of the directly acting receptor (i.e., M 3 ) in competitive antagonism studies and not that of the indirectly acting receptor (i.e., M 2 ) (Sawyer and Ehlert, 1999a; Ehlert, 2003b) . This model explains why it is difficult, if not impossible, to detect a role for the M 2 receptor using competitive antagonists in experiments where a simultaneous activation of both M 2 and M 3 receptors occurs. This rationale also explains the large loss of the muscarinic contractile function in smooth muscle from M 3 KO mice. If the action of the M 2 receptor is contingent upon M 3 receptor activation, then the M 2 response will also be lost in the M 3 KO mouse.
Because of these limitations, a method was developed to isolate the indirect contractile response of the M 2 receptor from the direct response of the M 3 in competitive antagonism experiments on isolated smooth muscle (Thomas et al., 1993) . The method involves first inactivating M 3 receptors with a selective nitrogen mustard derivative (4-DAMP mustard) and then measuring the contractile response to a muscarinic agonist in the presence of heterologous contractile (e.g., histamine) and relaxant (forskolin) agents. Using this approach, it has been demonstrated that M 2 receptors mediate an inhibition of the relaxant effect of forskolin, and in some instances isoproterenol, on histamine-induced contractions of the colon Ehlert, 1998, 1999b) , ileum (Thomas et al., 1993; Thomas and Ehlert, 1994) , esophagus (Eglen et al., 1996) , and trachea (Thomas and Ehlert, 1996; Ehlert, 1998, 1999) and also on KCl-induced contractions of rat urinary bladder (Hegde et al., 1997) . However, no indirect mechanism for the M 2 receptor was detected in mouse urinary bladder using the same approach (Choppin and Eglen, 2001) .
In the present report, we have investigated an indirect role for the M 2 receptor in mouse urinary bladder using tissue from wild-type, M 2 KO, M 3 KO, and M 2 /M 3 KO mice. Our results are consistent with the postulate that the M 2 receptor mediates an inhibition of the relaxant effects of isoproterenol and forskolin on contractions mediated by prostaglandin FP and muscarinic M 3 receptors. We also obtained evidence that M 2 receptors enhance the contractile response to M 3 receptor activation in the absence of relaxant agents. Our results are consistent with a recent report demonstrating that the relaxant effects of isoproterenol and forskolin against muscarinic agonist-induced contractions are enhanced in urinary bladder from M 2 KO mice (Matsui et al., 2003) .
Materials and Methods
Isolated Urinary Bladder. M 2 muscarinic receptor knockout (M 2 Ϫ/Ϫ; M 2 KO), M 3 muscarinic receptor knockout (M 3 Ϫ/Ϫ; M 3 KO), and M 2 /M 3 muscarinic receptor double knockout (M 2 Ϫ/Ϫ, M 3 Ϫ/Ϫ; M 2 /M 3 KO) mice were generated in a mixed background between 129/SvJ and C57BL/6 as described in Matsui et al. (2002) and Matsui et al. (2000) , respectively. These hybrid lines were backcrossed with C57BL/6 mice to yield an N4 generation of M 2 KO mice, an N8 generation of M 3 KO mice, and an N2 generation of M 2 /M 3 KO mice, which were used in the pharmacological studies described herein. Only male knockout and wild-type (M 2 ϩ/ϩ, M 3 ϩ/ϩ) C57BL/6 mice were used. The mice were euthanized by CO 2 asphyxiation, and the whole urinary bladder was excised and used in contractile studies.
In most experiments, the whole urinary bladder was mounted longitudinally in tissue baths (50-ml capacity) with silk thread attached at the apex and at the outlet of the urinary bladder. In some experiments, the bladder was cut in half, and each half was mounted longitudinally in a similar fashion. The tissues were bathed at 37°C in 50 ml of Krebs-Ringer bicarbonate (124 mM NaCl, 5 mM KCl, 1.3 mM MgSO 4 , 26 mM NaHCO 3 , 1.2 mM KH 2 PO 4 , 1.8 mM CaCl 2 , and 10 mM glucose; KRB) buffer containing 1 M indomethacin and connected to force-displacement transducers. Isometric tension was recorded using a PowerLab (ADInstruments, Grand Junction, CO) recording system. Resting tension was adjusted to that generated by a mass of 1 g for the whole urinary bladder and to 0.5 g for the half urinary bladder strip. The tissues were allowed to equilibrate for at least 60 min prior to measurement of contractile responses. Three test doses of 50 mM KCl were applied to the tissues first, and subsequent contractile measurements were normalized relative to the third KCl test dose. Concentration-response curves to the muscarinic agonist oxotremorine-M were measured using a cumulative technique, essentially the same as that described previously (Matsui et al., 2003) . The bladder was allowed to rest for at least 30 min between consecutive measurements of the concentration-response curve to oxotremorine-M. When present, competitive antagonists were incubated with the bladder for 30 min prior to the measurement of contractile responses. In experiments where the irreversible muscarinic antagonist 4-DAMP mustard was used, the compound was first incubated at 37°C for 30 min in 10 mM sodium-potassium phosphate buffer, pH 7.4, to allow formation of the reactive aziridinium ion, essentially as described previously (Thomas et al., 1992) . Solutions of cyclized 4-DAMP mustard were kept on ice and used as soon as possible. Following treatment of the bladder with a combination of 4-DAMP mustard and AF-DX 116, the tissue was washed four times over a period of 30 min to remove AF-DX 116 and the transformation products of 4-DAMP mustard.
Calculations. An increasing logistic equation was fitted to the oxotremorine-M concentration-response curve by nonlinear regression analysis to estimate the maximal response (E max ), the concentration of oxotremorine-M eliciting a half-maximal response (EC 50 ), and the Hill slope, as described previously (Candell et al., 1990) . The dissociation constant (K B ) of competitive antagonists were estimated in contractile studies using K B ϭ [B]/CRϪ1 (Arunlakshana and Schild, 1959) , in which B denotes the concentration of the antagonist and CR denotes the EC 50 value of oxotremorine-M measured in the presence of the antagonist divided by that measured in its absence. The K B and EC 50 values were estimated in molar units and then converted to negative logarithms before statistical analysis. In most instances, a two-tailed Student's t test was used to determine the statistical significance of differences between parameter estimates.
Drugs and Chemicals. The reagents used in this study were obtained from the following sources: AF-DX 116, Boehringer Ingleheim USA (Ridgefield, CT); oxotremorine-M, Sigma RBI (Natick, MA); atropine, isoproterenol, and PGF 2␣ , Sigma-Aldrich (St. Louis, MO); and forskolin, Calbiochem (San Diego, CA). 4-DAMP was synthesized in our laboratory using a method similar to that described by Barlow et al. (1976) , and 4-DAMP mustard was synthesized as described previously (Thomas et al., 1992) .
Results
Contractile Activity of Oxotremorine-M and PGF 2a . Oxotremorine-M elicited contractions with high potency (pEC 50 ϭ 6.54) in urinary bladder from wild-type mice (Fig.  1a) . When expressed relative to the contraction elicited to 50 mM KCl, the E max value was calculated to be 326%. Oxotremorine-M exhibited similar contractile activity in urinary bladder from M 2 KO mice, although the potency and E max were both slightly lower [1.7-fold increase in EC 50 (P ϭ 0.012) and a nonsignificant 11% decrease in E max (P ϭ 0.64)]. In contrast, the contractile response to oxotremorine-M was greatly inhibited in urinary bladder from M 3 KO mice. This effect was characterized by a highly significant (P ϭ 4.3 ϫ 10 Ϫ6 ) 85% reduction in the E max without a significant change in EC 50 . It was impossible to detect contractile responses to oxotremorine-M in urinary bladder from M 2 /M 3 KO mice. The results in Fig. 1a are summarized in Table 1 .
We also investigated the effects of PGF 2␣ in the isolated urinary bladder (see Fig. 1b ). In contrast to oxotremorine-M, PGF 2␣ was much less potent in urinary bladder from wildtype (pEC 50 ϭ 5.48) and M 2 KO (pEC 50 ϭ 5.23) mice (see Fig.  1b ). Although we did not investigate high concentrations of PGF 2␣ that elicited clear maximal responses, the estimates of E max by regression analysis in wild-type and M 2 KO mice were 89 and 86%, respectively. In urinary bladder from mice lacking M 3 receptors, PGF 2␣ was much more active. The pEC 50 and E max values of PGF 2␣ in M 3 KO mice were 6.39 and 186%, respectively, and the corresponding values in M 2 /M 3 KO mice were 6.60 and 138%. Thus, the loss of M 3 receptor function in the urinary bladder from male mice seems to trigger an increase in sensitivity to PGF 2␣ . These results are summarized in Table 2 .
Competitive Antagonism. We investigated the ability of M 2 -selective (AF-DX 116) and M 3 -selective (4-DAMP) muscarinic antagonists to inhibit the contractile response to oxotremorine-M in urinary bladder from wild-type and muscarinic receptor KO mice. At a concentration of 1 M, AF-DX 116 only caused 3.0-and 2.1-fold shifts in the concentrationresponse curve to oxotremorine-M in urinary bladder from wild-type and M 2 KO mice. These data yield pK B estimates of 6.28 and 6.01, respectively. In contrast, the same concentration of AF-DX 116 caused an 11-fold shift in the oxotremorine-M concentration response in urinary bladder from M 3 KO mice, yielding a pK B estimate of 6.97. At a concentration of 10 nM, 4-DAMP shifted the oxotremorine-M concentration-response curve to the right 12-and 16-fold in urinary bladder from wild-type and M 2 KO mice, respectively, which yields pK B estimates of 9.03 and 9.19. These data are summarized in Table 3 together with the binding affinities of AF-DX 116 and 4-DAMP at recombinant human M 2 and M 3 receptors. The pK B values estimated in wild-type and M 2 KO mice agree with the binding affinity measured at M 3 receptors. In contrast, the pK B value measured for AF-DX 116 in the M 3 KO mouse agrees with the binding affinity at M 2 receptors.
4-DAMP Mustard Treatment. It has been shown that treatment of cell lines and native tissues with the aziri- dinium ion of 4-DAMP mustard in combination with AF-DX 116 causes a selective, irreversible alkylation of the recognition site of M 3 receptors while having little effect on M 2 receptors (Thomas et al., 1992 (Thomas et al., , 1993 Griffin et al., 2003) . By itself, 4-DAMP mustard exhibits moderate selectivity for M 3 receptors over M 2 , although it has the capacity to alkylate both receptors depending upon its concentration and length of incubation. By carrying out the incubation in the presence of the competitive, M 2 -selective antagonist AF-DX 116, it is possible to increase the apparent selectivity of 4-DAMP mustard for M 3 receptors by protecting the M 2 with AF-DX 116. Consequently, we were interested in examining the influence of 4-DAMP mustard treatment on the muscarinic contractile response in urinary bladder from wild-type and muscarinic receptor KO mice. Because of the instability of the aziridinium ion, urinary bladders were given two consecutive 1-h treatments with 10 nM 4-DAMP mustard in combination with 1 M AF-DX 116, with fresh drug solutions being used for the second treatment. The contractile activity of oxotremorine-M was assessed after each 1-h treatment. Treatment of urinary bladder from wild-type mice with 4-DAMP mustard caused a large shift to the right in the oxotremorine-M concentration-response curve after 1 h and a further shift to the right and decrease in E max after 2 h of treatment (see Fig. 2 ). Similar effects were observed in experiments on urinary bladder from M 2 KO mice except that the inhibitory effects of 4-DAMP mustard were greater and characterized by a larger depression in the E max of oxotremorine-M. In contrast, 4-DAMP mustard treatment had little influence on the contractile response to oxotremorine-M in the urinary bladder from M 3 KO mice. We did measure 2.4-and 2.7-fold shifts to the right in the oxotremorine-M concentrationresponse curve in these experiments after 1-and 2-h treatment with 4-DAMP mustard, respectively. However, control experiments showed that incubation of the mouse urinary bladder from M 3 KO mice with 1 M AF-DX 116 only for 1 and 2 h followed by four washes over 30 min cause similar 3.3-and 4.7-fold shifts, respectively, in the concentrationresponse curves. In contrast, incubating the urinary bladder from M 3 KO mice in the absence of any drugs for several hours caused no change in its sensitivity to oxotremorine-M. Consequently, the small shift in the concentration-response curve to oxotremorine-M noted in urinary bladder from M 3 KO mice after 4-DAMP mustard treatment can be attributed to residual AF-DX 116 in the tissue and not to inactivation of muscarinic receptors with 4-DAMP mustard. The results in Fig. 2 are consistent with the postulate that the M 3 receptor mediates most of the direct contractile response in the urinary bladder from wild-type and M 2 KO mice, whereas the 4-DAMP mustard-insensitive M 2 receptor mediates contraction in the M 3 KO mouse urinary bladder. These results are summarized in Table 4 . Although the contractile response to oxotremorine-M was greatly inhibited by 4-DAMP mustard in urinary bladder from both wild-type and M 2 KO mice, the response in M 2 KO mice was inhibited more. Figure 3a shows a plot of the concentration-response curves to oxotremorine-M in urinary bladder from wild-type and M 2 KO mice after 1-and 2-h treatment with 4-DAMP mustard. The larger size of the responses in wild-type bladder relative to those measured in M 2 KO bladder is readily apparent. These results suggest that the M 2 receptor partially rescues contraction in the urinary bladder from wild-type mice after most of the M 3 receptors have been inactivated with 4-DAMP mustard. To investigate the nature of the interaction between M 2 and M 3 receptors, we measured the competitive antagonism of contraction in wild-type urinary bladder after 2-h 4-DAMP mustard treatment. In these experiments, urinary bladder was first treated with 4-DAMP mustard for 2 h and washed, and then a concentration-response curve to oxotremorine-M was measured. The tissue was washed and incubated with AF-DX 116 or 4-DAMP for 30 min, and contractions were measured again in the presence of the antagonist. However, control experiments without the antagonist showed that there was some small recovery from 4-DAMP mustard treatment during the 30 min after measurement of the first concentrationresponse curve-the pEC 50 value of oxotremorine-M increased by 0.17 Ϯ 0.071 log units (1.5-fold increase in potency), and the E max increased by 33 Ϯ 7%. Thus, in these experiments, the antagonist induced shifts were corrected for the slow recovery from 4-DAMP mustard blockade. Following 4-DAMP mustard treatment, 1 M AF-DX 116 caused a 1.6-fold shift in the oxotremorine-M concentration response curve, whereas 10 nM 4-DAMP caused a 8.5-fold shift (see Fig. 3, b and c) . When these shifts were corrected for recovery of the oxotremorine-M response, the calculated pK B values of AF-DX 116 and 4-DAMP were 6.09 Ϯ 0.098 and 9.06 Ϯ 0.047, respectively. These values are in close agreement with the binding affinities of AF-DX 116 (pK D ϭ 6.10) and 4-DAMP (pK D ϭ 8.81) for recombinant human M 3 receptors but not M 2 receptors (i.e., 7.27 and 7.87, respectively). Thus, competitive antagonism experiments in wild-type urinary bladder after inactivation of a majority of the M 3 receptors with 4-DAMP mustard provides no evidence for a role of the M 2 receptor. Nevertheless, as described in the Introduction and under Esqueda et al. (1996) . Table 4.   TABLE 4 Effects of 4-DAMP mustard treatment on the contractile response to oxotremorine-M in urinary bladder from wild-type, M 2 KO, and M 3 KO mice
The data were calculated from the experiments shown in Fig. 2 . 4-DAMP mustard treatment was accomplished by incubating urinary bladder with 10 nM 4-DAMP mustard in combination with 1 M AF-DX 116 for the indicated times. The number of experiments is indicated in parentheses in the column on the left. Each experiment was done on urinary bladder from a different mouse. Discussion, the antagonist profile for a response mediated through a directly acting M 3 receptor and an indirectly acting M 2 receptor tends to resemble the profile of the M 3 receptor and not that of the M 2 receptor. Effects of Isoproterenol and Forskolin. As described in the Introduction, it is possible to measure indirect, M 2 receptor-mediated contractions in guinea pig smooth muscle by first inactivating M 3 receptors with 4-DAMP mustard and then measuring contraction to a muscarinic agonist in the presence of both a contractile (e.g., histamine) and cAMPgenerating relaxant agent (isoproterenol). Presumably, under these conditions, M 2 receptors mediate an inhibition of relaxation, thereby allowing histamine to elicit contraction. Consequently, we were interested in using urinary bladder from M 3 KO mice in this experimental paradigm. M 3 KO mice are devoid of M 3 receptors; thus, it should be possible to measure contractions mediated indirectly by the M 2 receptor without interference from the M 3 and without the necessity of 4-DAMP mustard treatment. The latter is never completely effective in eliminating the contractile response of the M 3 receptor. In these experiments, isolated urinary bladder from M 3 KO mice was first contracted with 1 M PGF 2␣ . After approximately 1 min, the contractile response to PGF 2␣ reached a stable plateau. At this time, 1 M isoproterenol or 10 M forskolin was added, which causes a complete relaxation of the PGF 2␣ -induced contraction. Then, in the continued presence of PGF 2␣ and the relaxant agent, a cumulative concentration-response curve to oxotremorine-M was measured. Figure 4 shows the results of these experiments. In the presence of 1 M PGF 2␣ and 1 M isoproterenol, oxotremorine-M elicits a potent contractile response characterized by mean pEC 50 and E max values Ϯ S.E.M. of 6.87 Ϯ 0.10 and 114 Ϯ 10%, respectively (Fig. 4a) . When forskolin was used as the relaxant agent, the pEC 50 and E max values of oxotremorine-M were 6.58 Ϯ 0.061 and 99 Ϯ 18%, respectively. The E max value of oxotremorine-M under these condi- jpet.aspetjournals.org tions was much greater than the E max value of oxotremorine-M measured in the absence of PGF 2␣ and the relaxant agents (about 30 -50%; Figs. 1a and 2c) . Thus, most of the contraction in these experiments represents an oxotremorine-M-mediated inhibition of the relaxant effects of forskolin and isoproterenol on PGF 2␣ -induced contractions and not simply a direct, M 2 receptor-mediated contraction. Oxotremorine-M was without effect in urinary bladder from M 2 /M 3 KO mice under these conditions, indicating that the indirect contractile response in M 3 KO mouse urinary bladder was mediated by the M 2 receptor.
1-h 4-DAMP Mustard Treatment
Since the foregoing data demonstrate that the M 2 receptor in urinary bladder from M 3 KO mice mediates a substantial contraction, we predicted that M 2 -selective antagonists should inhibit this response with high potency. To test this postulate, we measured the ability of 1 M AF-DX 116 to inhibit the contractile response to oxotremorine-M in the presence of 0.6 to 1.0 M PGF 2␣ and either 0.6 M isoproterenol or 10 M forskolin. When isoproterenol was used, AF-DX 116 caused a 6.9-fold shift in the concentrationresponse curve, whereas a 11.2-fold shift was noted when forskolin was present (Fig. 5) . These shifts yield mean pK B estimates Ϯ S.E.M. of 6.77 Ϯ 0.05 and 7.01 Ϯ 0.076 for AF-DX 116 in experiments with isoproterenol and forskolin, respectively. These values are in closer agreement with the binding affinity of AF-DX 116 at M 2 muscarinic receptors (pK D ϭ 7.27) compared with that of M 3 receptors (pK D ϭ 6.10).
We also investigated whether the M 2 receptor could mediate contractions under similar conditions in urinary bladder from wild-type mice that had been treated with 4-DAMP mustard to inactivate M 3 receptors. In these experiments, urinary bladder was incubated with 10 nM 4-DAMP mustard in combination with 1 M AF-DX 116 for a total of 2 h as described under Materials and Methods. Contractions to oxotremorine-M were subsequently measured in the presence of KCl and either 1 M isoproterenol (Fig. 6a) or 10 M forskolin (Fig. 6b) . Since PGF 2␣ exhibited low activity in urinary bladder from wild-type mice (see Fig. 1b ), we used KCl as the heterologous contractile agent in these experiments. We found that isoproterenol and forskolin caused a complete inhibition of the KCl response when KCl was present at a concentration of 37.5 mM but no higher. Consequently, we used KCl at a concentration of 37.5 mM for these experiments. When measured after 4-DAMP mustard treatment and in the presence of KCl and isoproterenol, oxotremorine-M elicited contractions in urinary bladder from wildtype mice that were characterized by mean pEC 50 and E max values Ϯ S.E.M. of 6.19 Ϯ 0.15 and 311 Ϯ 21%, respectively. The corresponding values in urinary bladder from M 2 KO mice were smaller (5.57 Ϯ 0.22 and 189 Ϯ 45%, respectively). The reduction in agonist potency (4.2-fold increase in EC 50 ) in the M 2 KO mouse was statistically significant (P ϭ 0.032), whereas the 39% decrease in E max was not quite significant (P ϭ 0.067). When measured under similar conditions in wild-type mice using forskolin as the relaxant agent, the mean pEC 50 and E max values Ϯ S.E.M. of oxotremorine-M were 5.89 Ϯ 0.16 and 285 Ϯ 37%, respectively. The corresponding values in urinary bladder from M 2 KO mice were smaller (5.55 Ϯ 0.21 and 105 Ϯ 27%, respectively). In these experiments, the 63% reduction in E max in the M 2 KO mouse was statistically significant (P ϭ 0.017), whereas the reduction in agonist potency (2.2-fold increase in EC 50 ) was not (P ϭ 0.26).
It is important to note that, with regard to the data in Fig.  6 , the E max values of oxotremorine-M measured in urinary bladder from wild-type mice greatly exceeded the initial contraction elicited by 37.5 mM KCl. This latter concentration of KCl elicited a contraction that was approximately 69 Ϯ 8.7% of that elicited by the standard test concentration of 50 mM KCl. Thus, the oxotremorine-M-induced contractions in wildtype bladder shown in Fig. 6 cannot only be attributed to a simple reversal of relaxation but must also involve a substantial direct muscarinic contractile component, probably mediated in part through residual M 3 receptors not inactivated by 4-DAMP mustard.
We also measured the ability of AF-DX 116 and 4-DAMP to antagonize the contractile response to oxotremorine-M in wild-type mice under the conditions of the experiments shown in Fig. 6 . When measured after 4-DAMP mustard treatment and in the presence of KCl and isoproterenol, 1 M AF-DX 116 and 10 nM 4-DAMP shifted the oxotremorine-M concentration-response curve to the right 3.7-and 3.5-fold, respectively (Fig. 7a) . These values represent shifts that were corrected for the time-dependent recovery of contraction after 4-DAMP mustard treatment as described above, in connection with the data shown in Fig. 3, b and c. The corresponding mean pK B estimates Ϯ S.E.M. of AF-DX 116 and 4-DAMP were 6.43 Ϯ 0.10 and 8.40 Ϯ 0.060, respectively. When these experiments were repeated under the same conditions, but with isoproterenol replaced with forskolin (see Fig. 7b ), the mean pK B values Ϯ S.E.M. of AF-DX 116 and 4-DAMP were 6.45 Ϯ 0.21 and 8.74 Ϯ 0.090, respectively. The pK B values of AF-DX 116 (approximately 6.4) and 4-DAMP (approximately 8.6) in these experiments were in closer agreement with their respective binding affinities (pK D valules) for M 3 receptors (6.10 and 8.81) compared with M 2 receptors (7.27 and 7.87). Thus, although the data in Fig.  6 demonstrate a substantial loss of contractile function in the urinary bladder from M 2 KO mice, the pharmacological antagonism experiments provide little evidence for an M 2 response. As described under Discussion, these results can be 
Discussion
Our results on the contractile effects of oxotremorine-M in urinary bladder are consistent with previous reports showing little loss of muscarinic contractile function in M 2 KO mice (Stengel et al., 2000; Matsui et al., 2002) , a very large loss of function in M 3 KO mice (Matsui et al., 2000) and a complete loss of function in M 2 /M 3 KO mice (Matsui et al., 2002) . We also noted that male mice lacking M 3 muscarinic receptors exhibited a large increase in sensitivity to the contractile effects of PGF 2␣ in urinary bladder. Perhaps this increase in sensitivity may partially compensate for the substantial urinary bladder distension that occurs in male M 3 KO and M 2 /M 3 KO mice (Matsui et al., 2000 (Matsui et al., , 2002 . In contrast, female mice lacking M 3 receptors do not exhibit urinary bladder distension (Matsui et al., 2000) nor an increased sensitivity to PGF 2␣ (data not shown). We have previously observed a modest increase in sensitivity to PGF 2␣ in ileum from M 2 KO and M 3 KO mice (Matsui et al., 2003) .
As reported by others, we found that competitive antagonists inhibited the muscarinic contractile response in urinary bladder from wild-type and M 2 KO mice in a manner consistent with an M 3 response, whereas behavior consistent with an M 2 response was observed in tissue from the M 3 KO mouse (Matsui et al., 2000; Stengel et al., 2000) . We also noted that the contractile response to oxotremorine-M in urinary bladder from wild-type and M 2 KO mice was greatly inhibited by 4-DAMP mustard treatment, whereas that observed in the M 3 KO mouse was unaffected. These results are consistent with the postulate that the M 3 receptor is the major muscarinic subtype generating the direct contractile response in wild-type and M 2 KO mice, because 4-DAMP mustard treatment (i.e., 10 nM 4-DAMP and 1 M AF-DX 116) has been shown to inactivate M 3 receptors selectively while having little effect on M 2 receptors .
Although 4-DAMP mustard treatment is effective in alkylating M 3 receptors with high selectivity, it is difficult to inactivate M 3 receptors completely with this agent. Furchgott analysis (Furchgott, 1966) of the contractile measurements in urinary bladder from M 2 KO mice after 1 and 2 h of 4-DAMP mustard treatment yields estimates of 8.5 and 1.5%, respectively, for the fraction of residual M 3 receptors mediating contraction. It may be impossible to inactive M 3 receptors much beyond this level using our 2-h treatment paradigm, because even a very small percentage of new receptors being transported to the sarcolemma during the wash period (30 -40 min) could restore contractile function to the levels that we observe.
When measured after 4-DAMP mustard treatment, the contractile responses to oxotremorine-M were much greater in wild-type than in M 2 KO mice, particularly when oxotremorine-M was used in the concentration range of 0.05 to 1.5 M (see Fig. 3a ). This difference in contractile function between wild-type and M 2 KO mice amounted to 78 to 162% of the response to 50 mM KCl. It follows that the M 2 component of contraction in wild-type mice under these conditions is equivalent to 78 to 162% of the KCl-induced contraction. However, this M 2 component is much greater than the E max value of oxotremorine-M in urinary bladder from M 3 KO mice, which was only 30 to 50% of the KCl response. Thus, the contractile mechanism of the M 2 receptor in wild-type urinary bladder seems much greater than the direct M 2 receptor-mediated contractions observed in M 3 KO mice. This situation suggests that the M 2 component in wild-type urinary bladder is not a direct contraction but rather an M 2 receptor-mediated enhancement in the contractile response of the M 3 receptor. If this M 2 mechanism is less potent than the direct contractile mechanism of the M 3 receptor, this condition could explain why this M 2 mechanism is more apparent after M 3 receptors in wild-type urinary bladder have been inactivated with 4-DAMP mustard. A related phenomenon has been reported in guinea pig colon. The muscarinic contractile response of this tissue exhibits an M 3 profile in competitive antagonism studies and is insensitive to pertussis toxin, which uncouples M 2 receptor-mediated responses Ehlert, 1998, 1999b) . However, after extensive inactivation of M 3 receptors, the residual muscarinic contractile response is greatly inhibited by pertussis toxin treatment, suggesting a role for the M 2 receptor. However, this residual contractile response exhibits an M 3 profile in competitive antagonism experiments, just like that of the wild-type mouse urinary bladder after 4-DAMP mustard treatment. As described above, this behavior is consistent with a model in which the M 2 receptor acts indirectly to enhance the direct contractile response of the M 3 receptor. Mathematical modeling shows that this interaction has a tendency to exhibit an M 3 profile in competitive antagonism studies (Sawyer and Ehlert, 1999b; Ehlert, 2003b) .
Previous studies have demonstrated that it is possible to measure relatively pure M 2 muscarinic contractile responses in wild-type smooth muscle from guinea pigs by first inactivating M 3 receptors with 4-DAMP mustard and then measuring muscarinic agonist-induced contractions in the presence of histamine and isoproterenol or forskolin (Thomas et al., 1993) . These contractions are pertussis toxin-sensitive (Thomas and Ehlert, 1994) and exhibit an M 2 profile in competitive antagonism experiments (Ehlert and Thomas, 1995) . A limitation in this experiment is that it is difficult to eliminate the contractile response of the M 3 receptor completely. Consequently, we were interested in exploring this paradigm in M 3 KO mouse bladder, in which the problem of M 3 receptor-mediated contractions is obviously precluded. We found that oxotremorine-M mediated substantial contractions when measured in the presence of PGF 2␣ and either forskolin or isoproterenol in M 3 KO mouse urinary bladder. These contractions were completely eliminated in M 2 /M 3 KO mouse bladder, indicating that they were mediated by the M 2 receptor. In addition, the M 2 selective antagonist AF-DX 116 potently antagonized these contractions. The contractile mechanism probably involves an M 2 receptor-mediated inhibition of the relaxant effect of isoproterenol and forskolin on PGF 2␣ -mediated contractions. This M 2 mechanism should act to diminish relaxant effects on contractile receptors other than those for PGF 2␣ (i.e., prostaglandin FP). We have shown that the relaxant effects of isoproterenol and forskolin against muscarinic agonist-induced contractions are enhanced in M 2 KO mouse urinary bladder (Matsui et al., 2003) . Collectively, these results demonstrate that muscarinic agonists activate both M 2 and M 3 receptors in urinary bladder and that activation of the M 2 receptor inhibits the We were unable to demonstrate a role for the M 2 receptor in wild-type mouse urinary bladder in competitive antagonism studies after 4-DAMP mustard treatment, although there was a large loss of contractile function in M 2 KO mouse urinary bladder under the same conditions. These results can be explained by the nature of the interaction between M 2 and M 3 receptors under these conditions. Even in the presence of KCl and relaxant agents (Fig. 6) , most of the M 2 contractile mechanism in our experiments on wild-type urinary bladder involves an enhancement in M 3 contractile function, either by inhibiting relaxation (Fig. 6) or directly enhancing M 3 -mediated contractions (Figs. 2a and 3a) . We have previously shown that this type of interaction exhibits an M 3 profile in competitive antagonism experiments (Sawyer and Ehlert, 1999b; Ehlert, 2003b) . The paradigm used for the experiments shown in Fig. 6 has the capacity to reveal M 2 responses in competitive antagonism studies. However, to do so, it is necessary to inactivate M 3 receptors effectively and use a heterologous contractile agent that elicits a substantial contraction that is greatly inhibited by the relaxant agent. In our experiments, we were unable to generate sizable contractions to KCl that were sensitive to isoproterenol or forskolin. Moreover, we could not overcome this limitation through more effective inactivation of M 3 receptors. Our results show the utility of muscarinic KO mice for addressing muscarinic function in this situation.
Studies on human urinary bladder have shown an abundance of M 2 muscarinic receptors (Kories et al., 2003) and a large cholinergic component to the contractile response to electrical field stimulation (Sibley, 1984) , suggesting a role for M 2 mechanisms in the contraction of human urinary bladder. Nevertheless, several investigators have suggested that cholinergic contractions are mediated exclusively by M 3 receptors, because the pharmacological antagonism of the muscarinic contractile response in human urinary bladder exhibits an M 3 profile (Fetscher et al., 2002) . If one considers the possibility of two receptors, then the data are also not inconsistent with an M 2 /M 3 interaction, in which the M 2 receptor enhances the direct contractile action of the M 3 receptor through a mechanism contingent upon M 3 -receptor activation. As mentioned above, this model exhibits an M 3 profile in competitive antagonism studies (Ehlert, 2003a,b) . Thus, our results showing a substantial indirect role for the M 2 receptor in mediating contraction of the urinary bladder suggest that muscarinic antagonists with high affinity for both M 2 and M 3 receptors may be more useful in the treatment of urinary incontinence in humans than antagonists with selectivity for the M 3 receptor only.
